Starmer's team have had a rocky ride – but have at least won plaudits from the co-op movement with their efforts to grow the ...

Senior MPs and privacy campaigners have expressed alarm at the deployment of Palantir’s AI-powered crime-fighting software ...

Palantir Stock Has Surged, but Some See Growing Reputational Risks Palantir is up 80% in 2025 amid new reports questioning its work for the US government.

Palantir’s entry into the UK’s NHS is very worrying as the company has a terrifying track record and deep ties with the ongoing genocide in Gaza, argues Steven McWilliam In November of 2023, the NHS ...

A report for a Northern England health authority says its analytics platform is more capable than anything offered under a controversial central government deal with Palantir. The Greater Manchester ...

English hospitals are voicing their concern about the functionality provided by Palantir, the US spy-tech firm that won a £330 million ($437 million) deal to run the Federated Data Platform for NHS ...

Palantir Technologies, the controversial US spy-tech firm, is once again set to be a sponsor of this year’s NHS Confederation Expo, an event jointly delivered with NHS England. The company, co-founded ...

Shares of Palantir Technologies (NASDAQ:PLTR) tumbled 12% Tuesday morning after the artificial intelligence data analytics firm handily beat analyst first-quarter revenue and earnings forecasts ...

The Palantir problem The American firm’s huge NHS contract raises equally big questions about government and tech.

Palantir handling NHS data in the UK is dangerous & shows the acceleration of techno fascism isn’t limited to the US, warns Dr Rhiannon Mihranian Osborne.

Palantir, the $160 billion (€152 billion) US surveillance company at the centre of the farrago around suspended Social Democrats TD Eoin Hayes, is no stranger to controversy.